Teva Pharmaceutical Industries Ltd. is preparing for a “swift appeal as well as continuing to pursue a mistrial” after a jury in New York held that the Israeli firm’s US affiliate did help fuel the opioid epidemic in the state. A determination for damages against Teva is set to be decided at a trial later this year.
After a six-month trial, a six-member jury has issued a verdict finding that Teva and certain of its affiliates, including...






